TORONTO, Dec. 21, 2023 (GLOBE NEWSWIRE) — Platinex Inc. (CSE: PTX, OTCQB: PANXF, Frankfurt: 9PX) (“Platinex” or the “Company”) is pleased to announce […]
Biodexa Pharmaceuticals PLC(“Biodexa” or the “Company”) Biodexa Announces Closing Of $6.0 Million Underwritten Public Offering, Including Full Exercise Of Overallotment […]